Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment

Yanqing Zhu, Hitomi Kataoka, Kumar Sharma

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Summary: The recognition that the drivers of matrix accumulation is an appropriate therapeutic target for diabetic nephropathy is now accepted by the nephrology and pharmaceutical communities. Interventions focused around transforming growth factor-β (TGF-β) likely will be an important area of clinical investigation in the near future. Understanding the various pathways involved in stimulating TGF-β in the diabetic kidney is of paramount importance in devising strategies to combat the development and progression of diabetic nephropathy. In this review we highlight the major pathways involved in stimulating TGF-β production by increased glucose levels and discuss the therapeutic implications thereof.

Original languageEnglish
Pages (from-to)153-160
Number of pages8
JournalSeminars in Nephrology
Volume27
Issue number2
DOIs
Publication statusPublished - Mar 2007
Externally publishedYes

Fingerprint

Diabetic Nephropathies
Transforming Growth Factors
Nephrology
Kidney
Glucose
Therapeutics
Pharmaceutical Preparations

Keywords

  • decorin
  • glucose excursion
  • HETE
  • macrophages
  • podocytes
  • Protein kinase C
  • reactive oxygen species
  • thrombospondin
  • upstream stimulatory factor

ASJC Scopus subject areas

  • Nephrology

Cite this

Regulation of Transforming Growth Factor β in Diabetic Nephropathy : Implications for Treatment. / Zhu, Yanqing; Kataoka, Hitomi; Sharma, Kumar.

In: Seminars in Nephrology, Vol. 27, No. 2, 03.2007, p. 153-160.

Research output: Contribution to journalArticle

@article{ca6c5de2bde94de2a72e8579c18992aa,
title = "Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment",
abstract = "Summary: The recognition that the drivers of matrix accumulation is an appropriate therapeutic target for diabetic nephropathy is now accepted by the nephrology and pharmaceutical communities. Interventions focused around transforming growth factor-β (TGF-β) likely will be an important area of clinical investigation in the near future. Understanding the various pathways involved in stimulating TGF-β in the diabetic kidney is of paramount importance in devising strategies to combat the development and progression of diabetic nephropathy. In this review we highlight the major pathways involved in stimulating TGF-β production by increased glucose levels and discuss the therapeutic implications thereof.",
keywords = "decorin, glucose excursion, HETE, macrophages, podocytes, Protein kinase C, reactive oxygen species, thrombospondin, upstream stimulatory factor",
author = "Yanqing Zhu and Hitomi Kataoka and Kumar Sharma",
year = "2007",
month = "3",
doi = "10.1016/j.semnephrol.2007.01.008",
language = "English",
volume = "27",
pages = "153--160",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Regulation of Transforming Growth Factor β in Diabetic Nephropathy

T2 - Implications for Treatment

AU - Zhu, Yanqing

AU - Kataoka, Hitomi

AU - Sharma, Kumar

PY - 2007/3

Y1 - 2007/3

N2 - Summary: The recognition that the drivers of matrix accumulation is an appropriate therapeutic target for diabetic nephropathy is now accepted by the nephrology and pharmaceutical communities. Interventions focused around transforming growth factor-β (TGF-β) likely will be an important area of clinical investigation in the near future. Understanding the various pathways involved in stimulating TGF-β in the diabetic kidney is of paramount importance in devising strategies to combat the development and progression of diabetic nephropathy. In this review we highlight the major pathways involved in stimulating TGF-β production by increased glucose levels and discuss the therapeutic implications thereof.

AB - Summary: The recognition that the drivers of matrix accumulation is an appropriate therapeutic target for diabetic nephropathy is now accepted by the nephrology and pharmaceutical communities. Interventions focused around transforming growth factor-β (TGF-β) likely will be an important area of clinical investigation in the near future. Understanding the various pathways involved in stimulating TGF-β in the diabetic kidney is of paramount importance in devising strategies to combat the development and progression of diabetic nephropathy. In this review we highlight the major pathways involved in stimulating TGF-β production by increased glucose levels and discuss the therapeutic implications thereof.

KW - decorin

KW - glucose excursion

KW - HETE

KW - macrophages

KW - podocytes

KW - Protein kinase C

KW - reactive oxygen species

KW - thrombospondin

KW - upstream stimulatory factor

UR - http://www.scopus.com/inward/record.url?scp=34147159558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147159558&partnerID=8YFLogxK

U2 - 10.1016/j.semnephrol.2007.01.008

DO - 10.1016/j.semnephrol.2007.01.008

M3 - Article

C2 - 17418684

AN - SCOPUS:34147159558

VL - 27

SP - 153

EP - 160

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 2

ER -